Marina Fasolini
Nerviano Medical Sciences(IT)
Publications by Year
Research Areas
Hereditary Neurological Disorders, Protein Kinase Regulation and GTPase Signaling, Cellular Mechanics and Interactions, Lung Cancer Treatments and Mutations, Cancer therapeutics and mechanisms
Most-Cited Works
- → Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor(2016)295 cited
- → P0‐Cre Transgenic Mice for Inactivation of Adhesion Molecules in Schwann Cells(1999)208 cited
- → Inhibition of protein–protein interactions: The discovery of druglike β‐catenin inhibitors by combining virtual and biophysical screening(2006)179 cited
- → Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy(2015)141 cited
- → Tetramerization Dynamics of C-terminal Domain Underlies Isoform-specific cAMP Gating in Hyperpolarization-activated Cyclic Nucleotide-gated Channels(2011)127 cited
- → NMR-Based Screening with Competition Water−Ligand Observed via Gradient Spectroscopy Experiments: Detection of High-Affinity Ligands(2002)114 cited
- → NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor(2011)104 cited
- → Structural basis for CARM1 inhibition by indole and pyrazole inhibitors(2011)97 cited
- → Hot Spots in Tcf4 for the Interaction with β-Catenin(2003)88 cited
- → First Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potent and Orally Active Antitumor Agents. 2. Lead Discovery(2008)66 cited